X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (64) 64
Book / eBook (18) 18
Newspaper Article (10) 10
Web Resource (3) 3
Conference Proceeding (2) 2
Book Chapter (1) 1
Patent (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atrial fibrillation (16) 16
stroke (14) 14
humans (13) 13
index medicus (12) 12
warfarin (11) 11
aged (10) 10
female (10) 10
male (10) 10
dabigatran (9) 9
middle aged (9) 9
cardiac arrhythmia (8) 8
cardiovascular (8) 8
care and treatment (8) 8
abridged index medicus (7) 7
authors, french (7) 7
correspondence (7) 7
internal medicine (7) 7
stroke - prevention & control (7) 7
anticoagulants (6) 6
atrial fibrillation - complications (6) 6
gide, andré (6) 6
registries (6) 6
aged, 80 and over (5) 5
atrial fibrillation - drug therapy (5) 5
biography (5) 5
cardiac & cardiovascular systems (5) 5
dabigatran - therapeutic use (5) 5
environmental education (5) 5
fibrinolytic agents - therapeutic use (5) 5
gide, andré, 1869-1951 (5) 5
oral anticoagulation (5) 5
risk (5) 5
risk factors (5) 5
stroke - etiology (5) 5
therapy (5) 5
analysis (4) 4
anticoagulants - adverse effects (4) 4
anticoagulants - therapeutic use (4) 4
antithrombins - therapeutic use (4) 4
euro heart survey (4) 4
french literature (4) 4
lighting (4) 4
management (4) 4
medicine, general & internal (4) 4
patients (4) 4
prevention (4) 4
prospective studies (4) 4
stroke prevention (4) 4
treatment outcome (4) 4
1869-1951 (3) 3
adjustment (3) 3
adult (3) 3
age (3) 3
alcohol (3) 3
anticoagulation (3) 3
atrial-fibrillation (3) 3
cities (3) 3
councils (3) 3
cross-sectional studies (3) 3
design (3) 3
drug therapy (3) 3
education & educational research (3) 3
fibrillation (3) 3
hematology (3) 3
hypertension (3) 3
journal article (3) 3
newly marketed medications (3) 3
peripheral vascular disease (3) 3
pharmacology & pharmacy (3) 3
registry (3) 3
safety (3) 3
warfarin - adverse effects (3) 3
20th century (2) 2
adherence (2) 2
adolescent (2) 2
antithrombins (2) 2
atrial fibrillation - epidemiology (2) 2
authors (2) 2
benzimidazoles - adverse effects (2) 2
beta-alanine - analogs & derivatives (2) 2
cardiovascular disease (2) 2
care (2) 2
chads-vasc score (2) 2
children and adult learning (2) 2
christmas (2) 2
clinical trials (2) 2
clothing industry (2) 2
cohort studies (2) 2
criticism and interpretation (2) 2
dabigatran - adverse effects (2) 2
databases (2) 2
diabetes (2) 2
discontinuation (2) 2
drug administration schedule (2) 2
ecology (2) 2
environmental studies (2) 2
esc guidelines (2) 2
evaluation (2) 2
events (2) 2
fibrinolytic agents - adverse effects (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
St. Michael's College (John M. Kelly) - 2nd Floor (8) 8
Robarts - Stacks (7) 7
UTL at Downsview - May be requested (7) 7
Victoria University E.J. Pratt - Stacks (5) 5
UofT at Scarborough - Stacks (2) 2
Music - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Victoria University E.J. Pratt - Storage (1) 1
Victoria University E.J. Pratt - Virginia Woolf (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 04/2018, Volume 198, pp. 55 - 63
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 6, pp. 1277 - 1289
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2018, Volume 39, Issue suppl_1
Journal Article
Value in Health, ISSN 1098-3015, 05/2019, Volume 22, pp. S121 - S121
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 07/2019, Volume 17, Issue 7, pp. 1033 - 1043
Essentials Unlike warfarin, treatment with DOACs do not require regular plasma level monitoring. We compared persistence of patients treated with DOACs... 
dabigatran | persistence | rivaroxaban | utilization | apixaban | SAFETY | COMPLETENESS | ADHERENCE | DISCONTINUATION | THERAPY | WARFARIN | PERIPHERAL VASCULAR DISEASE | NEWLY MARKETED MEDICATIONS | HEMATOLOGY | Rivaroxaban | Evaluation | Atrial fibrillation | Analysis | Apixaban
Journal Article
Journal Article